ARTICLE | Clinical News
Naloxone Hydrochloride Nasal Spray regulatory update
February 23, 2017 2:18 AM UTC
FDA issued a complete response letter to an NDA from Amphastar for Naloxone Hydrochloride 2 mg/0.5 mL Nasal Spray for emergency treatment of known or suspected opioid overdose. According to Amphastar,...
BCIQ Company Profiles